bf8b4e475b
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
112 lines
6.3 KiB
Markdown
112 lines
6.3 KiB
Markdown
---
|
||
type: "Bill"
|
||
title: "Prescription Drugs"
|
||
description: "Prescription Drugs; Citing this act as the \"Prescription Drug Reform Act\"; specifying additional prohibited acts related to the Florida Drug and Cosmetic Act; requiring certain drug manufacturers to notify the Department of Business and Professional Regulation of reportable drug price increases on a specified form on the effective date of such increase; requiring the Division of Consumer Services of the Department of Financial Services to designate an employee as the primary contact for consumer complaints involving pharmacy benefit managers; providing a grandfathering provision for certain pharmacy benefit managers operating as administrators; requiring pharmacy benefits plans and programs, beginning on a specified date, to annually submit a certain attestation to the Office of Insurance Regulation, etc."
|
||
jurisdiction: "us/states/fl"
|
||
legislature: "Florida Legislature"
|
||
session: "2023"
|
||
identifier: "SB 1550"
|
||
citation: "Florida SB 1550 (2023)"
|
||
classification: ["bill"]
|
||
subjects: ["(adopted)", "insurance"]
|
||
status: "enacted"
|
||
chapter_law: "2023-29"
|
||
primary_sponsors: ["Brodeur", "Fiscal Policy", "Health Policy"]
|
||
version_count: 6
|
||
action_count: 38
|
||
vote_count: 5
|
||
first_action: "2023-03-03"
|
||
last_action: "2023-05-04"
|
||
source: "openstates"
|
||
source_identifier: "ocd-bill/bd904415-ae13-47c2-8b85-29e69f9ee03a"
|
||
source_url: "https://flsenate.gov/Session/Bill/2023/1550/ByCategory"
|
||
source_hash: "d01340a8348bece6a6a91fa4097ee20533051c45f17db62a194263a1f550c9f8"
|
||
vintage: "2026-07-01"
|
||
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
|
||
retrieved_at: "2026-07-06"
|
||
confidence: "reported"
|
||
tags: ["legislation", "bill", "us-fl"]
|
||
---
|
||
|
||
# Florida SB 1550 (2023) — Prescription Drugs
|
||
|
||
Prescription Drugs; Citing this act as the "Prescription Drug Reform Act"; specifying additional prohibited acts related to the Florida Drug and Cosmetic Act; requiring certain drug manufacturers to notify the Department of Business and Professional Regulation of reportable drug price increases on a specified form on the effective date of such increase; requiring the Division of Consumer Services of the Department of Financial Services to designate an employee as the primary contact for consumer complaints involving pharmacy benefit managers; providing a grandfathering provision for certain pharmacy benefit managers operating as administrators; requiring pharmacy benefits plans and programs, beginning on a specified date, to annually submit a certain attestation to the Office of Insurance Regulation, etc.
|
||
|
||
**Enacted** — Laws of Florida, Chapter 2023-29.
|
||
|
||
## Version chain
|
||
|
||
The bill's text revisions, in order — the diff chain from filing to enrollment.
|
||
|
||
1. **S 1550 Filed** (filed) — [source](https://flsenate.gov/Session/Bill/2023/1550/BillText/Filed/HTML)
|
||
2. **S 1550 c1** (committee substitute) — [source](https://flsenate.gov/Session/Bill/2023/1550/BillText/c1/HTML)
|
||
3. **S 1550 c2** (committee substitute) — [source](https://flsenate.gov/Session/Bill/2023/1550/BillText/c2/HTML)
|
||
4. **S 1550 e1** (engrossed) — [source](https://flsenate.gov/Session/Bill/2023/1550/BillText/e1/HTML)
|
||
5. **S 1550 e2** (engrossed) — [source](https://flsenate.gov/Session/Bill/2023/1550/BillText/e2/HTML)
|
||
6. **S 1550 er** (enrolled) — [source](https://flsenate.gov/Session/Bill/2023/1550/BillText/er/HTML)
|
||
|
||
## Votes
|
||
|
||
- Returning Messages — **40–0** (pass) · upper
|
||
- Third Reading — **40–0** (pass) · upper
|
||
- Favorable with Committee Substitute — **12–0** (pass) · upper
|
||
- Favorable with Committee Substitute — **18–1** (pass) · upper
|
||
- Passage, Third Reading — **118–0** (pass) · lower
|
||
|
||
## Sponsors
|
||
|
||
- Brodeur — primary (person)
|
||
- Fiscal Policy — primary (person)
|
||
- Health Policy — primary (person)
|
||
- Perry — cosponsor (person)
|
||
- Rodriguez — cosponsor (person)
|
||
- Wright — cosponsor (person)
|
||
|
||
## Timeline
|
||
|
||
The legislative action history — every referral, reading, and vote.
|
||
|
||
- **2023-03-03** Filed `filing`
|
||
- **2023-03-09** Referred to Health Policy; Fiscal Policy `referral-committee`
|
||
- **2023-03-14** Introduced `introduction`
|
||
- **2023-03-22** On Committee agenda-- Health Policy, 03/27/23, 3:00 pm, 412 Knott Building
|
||
- **2023-03-27** CS by Health Policy; YEAS 12 NAYS 0
|
||
- **2023-03-29** Pending reference review under Rule 4.7(2) - (Committee Substitute)
|
||
- **2023-03-29** Now in Fiscal Policy
|
||
- **2023-03-29** CS by Health Policy read 1st time
|
||
- **2023-04-10** On Committee agenda-- Fiscal Policy, 04/13/23, 10:30 am, 412 Knott Building
|
||
- **2023-04-13** CS/CS by- Fiscal Policy; YEAS 18 NAYS 1
|
||
- **2023-04-14** Pending reference review -under Rule 4.7(2) - (Committee Substitute)
|
||
- **2023-04-14** Placed on Calendar, on 2nd reading
|
||
- **2023-04-14** Placed on Special Order Calendar, 04/18/23
|
||
- **2023-04-17** CS/CS by Fiscal Policy read 1st time
|
||
- **2023-04-18** Read 2nd time `reading-2`
|
||
- **2023-04-18** Amendment(s) adopted (392522, 438956, 633284, 704080)
|
||
- **2023-04-18** Ordered engrossed
|
||
- **2023-04-18** Placed on 3rd reading `reading-3`
|
||
- **2023-04-19** Read 3rd time `reading-3`
|
||
- **2023-04-19** CS passed as amended; YEAS 40 NAYS 0 `passage`
|
||
- **2023-04-19** Immediately certified
|
||
- **2023-04-19** In Messages
|
||
- **2023-04-28** Bill referred to House Calendar
|
||
- **2023-04-28** Bill added to Special Order Calendar (5/1/2023)
|
||
- **2023-04-28** 1st Reading (Engrossed 1) `reading-1`
|
||
- **2023-05-01** Read 2nd time `reading-2`
|
||
- **2023-05-01** Amendment 207723 adopted
|
||
- **2023-05-01** Placed on 3rd reading `reading-3`
|
||
- **2023-05-01** Added to Third Reading Calendar
|
||
- **2023-05-02** Read 3rd time `reading-3`
|
||
- **2023-05-02** CS passed as amended; YEAS 118, NAYS 0 `passage`
|
||
- **2023-05-02** In returning messages
|
||
- **2023-05-02** Concurred in 1 amendment(s) (207723)
|
||
- **2023-05-02** CS passed as amended; YEAS 40 NAYS 0 `passage`
|
||
- **2023-05-02** Ordered engrossed, then enrolled `enrolled`
|
||
- **2023-05-03** Signed by Officers and presented to Governor `executive-receipt`
|
||
- **2023-05-03** Approved by Governor `executive-signature`
|
||
- **2023-05-04** Chapter No. 2023-29, companion bill(s) passed, see CS/SB 1552 (Ch. 2023-30)
|
||
|
||
## Source
|
||
|
||
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/bd904415-ae13-47c2-8b85-29e69f9ee03a`. Confidence: reported (aggregated from official Florida legislature records).
|
||
|